Found: 7
Select item for more details and to access through your institution.
Novel Therapeutic Targets in Melanoma.
- Published in:
- 2023
- By:
- Publication type:
- Editorial
Tumour-derived SPARC drives vascular permeability and extravasation through endothelial VCAM1 signalling to promote metastasis.
- Published in:
- Nature Communications, 2015, v. 6, n. 4, p. 6993, doi. 10.1038/ncomms7993
- By:
- Publication type:
- Article
Inhibition of Melanogenesis by the Antidiabetic Metformin.
- Published in:
- Journal of Investigative Dermatology, 2014, v. 134, n. 10, p. 2589, doi. 10.1038/jid.2014.202
- By:
- Publication type:
- Article
Cancer cell metabolic reprogramming: a keystone for the response to immunotherapy.
- Published in:
- Cell Death & Disease, 2020, v. 11, n. 11, p. 1, doi. 10.1038/s41419-020-03175-5
- By:
- Publication type:
- Article
E2F1 inhibition mediates cell death of metastatic melanoma.
- Published in:
- Cell Death & Disease, 2018, v. 9, n. 5, p. 1, doi. 10.1038/s41419-018-0566-1
- By:
- Publication type:
- Article
Metformin monotherapy in melanoma: a pilot, open-label, prospective, and multicentric study indicates no benefit.
- Published in:
- Pigment Cell & Melanoma Research, 2017, v. 30, n. 3, p. 378, doi. 10.1111/pcmr.12576
- By:
- Publication type:
- Article
Is it time to test biguanide metformin in the treatment of melanoma?
- Published in:
- Pigment Cell & Melanoma Research, 2015, v. 28, n. 1, p. 8, doi. 10.1111/pcmr.12267
- By:
- Publication type:
- Article